{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:13:40Z","timestamp":1773339220134,"version":"3.50.1"},"reference-count":8,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2005,1,11]],"date-time":"2005-01-11T00:00:00Z","timestamp":1105401600000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1.\u2002The antitumour effect of orally administered cordycepin, a component isolated from water extracts of <jats:italic>Cordyceps sinensis<\/jats:italic>, was examined in mice inoculated with B16 melanoma (B16\u2010BL6) cells.<\/jats:p><jats:p>2.\u2002B16\u2010BL6 (1\u00a0\u00d7\u00a010<jats:sup>6<\/jats:sup>) cells were inoculated subcutaneously into the right footpad of mice. At 2\u00a0weeks after the cell inoculation, the enlarged primary tumour lump was weighed. Cordycepin (0, 5 and 15\u00a0mg\/kg per day) was administered orally to the mice for 2\u00a0weeks from the date of tumour inoculation. Cordycepin (15\u00a0mg\/kg per day) significantly reduced by 36% the wet weight of the primary tumour lump compared to that of the untreated control mice, without any loss of bodyweight or systemic toxicity.<\/jats:p><jats:p>3.\u2002Cordycepin (15\u00a0mg\/kg per day) administered orally for 2\u00a0weeks inhibited the tumour enlargement in the right thigh inoculated with B16\u2010BL6 cells premixed with extracellular matrix (Matrigel).<\/jats:p><jats:p>4.\u2002These results indicate that orally administered cordycepin inhibits melanoma cell growth in mice with no adverse effects.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2004.04108.x","type":"journal-article","created":{"date-parts":[[2005,1,11]],"date-time":"2005-01-11T09:56:53Z","timestamp":1105437413000},"source":"Crossref","is-referenced-by-count":57,"title":["ANTITUMOUR ACTIVITY OF CORDYCEPIN IN MICE"],"prefix":"10.1111","volume":"31","author":[{"given":"Noriko","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Kagota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Shinozuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kunitomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.79.335"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/713745176"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/166949a0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1016\/S0021-9258(20)79714-0","article-title":"Inhibition of nucleic acid methylation by cordycepin. In vivo synthesis of S\u20103\u2032\u2010deoxyadenosylmethionine by WI\u2010L2 human lymphoblasts","volume":"255","author":"Kredich NM","year":"1980","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(81)90031-3"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02359-2"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.18.7191"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00222a004"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2004.04108.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2004.04108.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T13:06:20Z","timestamp":1695819980000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2004.04108.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":8,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1440-1681.2004.04108.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2004.04108.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}